
|Videos|January 24, 2023
BMI and Background Comorbidities that Impact Plaque Psoriasis Treatment
Dermatology experts discuss BMI and other background comorbidities that can impact IL-23 inhibitors when treating plaque psoriasis.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
Single Annual Injection Produces Significant and Sustained Lp(a) Reductions
2
Ruvonoflast Reduces hsCRP, Inflammation, CVD Risk With Downstream Effects
3
One COPD Exacerbation Is Too Many: Vickram Tejwani, MD
4
RAPID: Etripamil Converts Two-Thirds of Recurrent PSVT Episodes After Ablation
5
















